Metastat Insights

Dialysis Devices Market

Dialysis Devices Market By Type (Hemodialysis Devices, Peritoneal Devices, and Continuous Renal Replacement Therapy (CRRT)), By End User (Hospitals, Clinics, Homecare Settings, and Ambulatory Surgical Centers), Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2021-2027.

Report ID

MSI-2374

Published

February, 2026

Pages

256 Pages

Format
Market Size 2026
Leadership Strategies
Key Trends
Market Size 2033

Report Details

Comprehensive Market Analysis And Insights

Market Definition

Global Dialysis Devices market was valued at $18,493.5 million in 2020 with a CAGR of 5.6% in forecast period.

Dialysis is the treatment that filters and purifies the blood using a machine. The Dialysis device helps to keep the fluids and electrolytes in balance when the kidneys is not able to operate properly. Dialysis has been used to treat people with kidney problems. There are two types of dialysis, hemodialysis dialysis and peritoneal dialysis.

Market Dynamics

Technological advancements in dialysis devices is a key driving factor of the market. For instance, Medtronic plc has introduced the Carpediem Cardio-Renal Pediatric Dialysis Emergency Machine. The company has received U.S. Food and Drug Administration's (FDA) marketing authorization, the first Carpediem systems in the United States were successfully installed and are in use at Cincinnati Children's Hospital Medical Center. The first of its kind Carpediem system is indicated for use in acute kidney injury or fluid overloaded patients requiring hemodialysis or hemofiltration therapy. Carpediem system is intended to provide continuous renal replacement therapy (CRRT) to patients weighing between 2.5 and 10 kilograms. Further, AWAK Technologies (AWAK), a pioneering medical technology company has announced the investigation for the safety of AWAK PD in dialysis treatment for patients with End Stage Renal Disease (ESRD) led by the Singapore General Hospital (SGH). However, product recall might hamper the market growth. For instance, Fresenius Medical Care has recalled two sets of its 4008 bloodlines (AV-Set B-R F00001124 and AV-Set SRB-R F00000257) containing a total of 25 batches experienced tube rupture that led to blood leakage. The dialysis machine do not detect the leaks, so Fresenius urged healthcare providers to immediately stop using the affected batches to avoid leaks and air entry to a patient’s bloodstream. Moreover, rising importance of home therapies would provide lucrative opportunities for the market in coming years.

Market Segmentation

The global dialysis devices market is mainly classified based on type and end user. Type is further segmented into Hemodialysis Devices, Peritoneal Devices, and Continuous Renal Replacement Therapy (CRRT). By end user the market is divided into Hospitals, Clinics, Homecare Settings, and Ambulatory Surgical Centers. 

Based on Type peritoneal devices segment is expected to be the fastest growing segment in the dialysis devices market during the forecasting period, owing to the rising investment for dialysis devices, collaboration between companies to develop and market peritoneal devices and increasing commercialization of regulatory approved dialysis devices. For instance, Fresenius Medical Care North America’s (FMCNA) Renal Therapies Group has introduced DELFLEX peritoneal dialysis solutions in Biofine, an innovative bag material that has been approved by the U.S. Food and Drug Administration (FDA). 

Regional Analysis

Based on geography, the global dialysis devices market is divided into North America, Europe, Asia-Pacific, South America, and Middle East & Africa. North America is further divided in the U.S., Canada, and Mexico, whereas Europe consists of the UK, Germany, France, Italy, and Rest of Europe. Asia-Pacific is segmented into India, China, Japan, South Korea, and Rest of Asia-Pacific. The South America region includes Brazil, Argentina, and the Rest of South America, while the Middle East & Africa is categorized into GCC Countries, Egypt, South Africa, and Rest of Middle East & Africa.

North America was dominating the dialysis devices market in 2020, owing to the rising prevalence of kidney failure, hypertension, increasing cases of diabetes, rising awareness by the government for the treatment of kidney, and introduction of dialysis devices in the U.S. Market. For instance, the Dialysis Care Center (DCC) introduce Baxter's Novel Theranova Dialyzer to U.S. market. Baxter Healthcare’s novel dialyzer deliver expanded hemodialysis (HDx) therapy, is used for patient care. The Theranova dialyzer’s membrane design offers a filtration profile that closely mimics that of the natural kidney and can be used with existing hemodialysis machines.

Competitive landscape

Key players operating in the dialysis devices industry include Baxter International, Medtronic, B Braun Melsungen, Fresenius Medical Care AG & Co. KGaA, NIPRO Corporation, Asahi Kasei Corporation Co., Ltd., Nikkiso Co., Ltd., Kawasumi Laboratories Inc., Toray Medical Co. Ltd., and JMS Co. Ltd.

Increasing commercialization of regulatory approved dialysis devices, facility expansion for the development of dialysis devices, rising investment for dialysis devices, and collaboration between companies to develop and market dialysis devices are some of the strategies adopted by the major companies. For instance, Fresenius Medical Care North America has collaborated with DaVita Inc. and other dialysis providers in response to COVID-19, with the aims to support the broader kidney care community in the United States by offering isolation capacity for dialysis patients. Fresenius Medical Care North America is cooperating with DaVita Inc., U.S. Renal Care, American Renal Associates, Satellite Healthcare and other dialysis organizations to create a nationwide contingency plan with a goal of help and maintain care for dialysis patients by creating isolation cohort capacity that can be accessed by dialysis providers.

Dialysis Devices Market Key Segments:

By Type

  • Hemodialysis Devices
  • Peritoneal Devices
  • Continuous Renal Replacement Therapy (CRRT)

By End User

  • Hospitals
  • Clinics
  • Homecare Settings
  • Ambulatory Surgical Centers

Key Global Dialysis Devices Industry Players

  • Baxter International
  • Medtronic
  • B Braun Melsungen
  • Fresenius Medical Care AG & Co. KGaA
  • NIPRO Corporation
  • Asahi Kasei Corporation Co., Ltd.
  • Nikkiso Co., Ltd.
  • Kawasumi Laboratories Inc.
  • Toray Medical Co. Ltd.
  • JMS Co. Ltd.

What Report Provides

  • Full in-depth analysis of the parent Industry
  • Important changes in market and its dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional growth potential
End of Report Overview

Frequently Asked Questions

Find answers to common questions about this report

No frequently asked questions available for this report.

Healthcare IT Research Team

The analysts below cover Healthcare IT research at Metastat Insights.

UTKARSH KHIRODKAR

LEAD ANALYST

Utkarsh Khirodkar is a Lead Market Research Analyst at MetaStat Insight, specializing in market intelligence, technology sector assessments, and competitive strategy.

AJAY DEVGIRE

LEAD PRINCIPAL ANALYST, PHARMA AND HEALTHCARE

Food and Beverages · Healthcare · Healthcare IT · Medical Devices

Ajay Devgire is the Lead Healthcare Analyst at MetaStat Insight, leading strategic research and market intelligence initiatives across the global healthcare domain.

VIJAY GUNTI

PRINCIPAL CONSULTANT - ENTERPRISE AI & EMERGING TECHNOLOGIES

Banking & Finance · Electronics and Semiconductor · Energy and Power · Healthcare IT · Information & Technology · Professional Services

Vijay Gunti is a Principal Consultant at MetaStat Insight, bringing over two decades of experience across enterprise digital transformation, technology strategy, and intelligent systems.

What our clients say

Transitioning ultra-class mining haul trucks to alternative power requires concrete data on remote hydrogen refueling infrastructure economics. The report evaluated megawatt-scale electrolyzer installation expenses, onsite storage safety mandates, and heavy-duty fuel cell stack degradation under continuous duty cycles. That technical rigor helped our engineers benchmark realistic total operating cost horizons for off-highway fleet decarbonization.
C

Caterpillar

Engineering Program Manager

Enterprise zero-trust network rollouts are often slowed down by multi-cloud transit latency and proprietary hardware retirement schedules. This study provided realistic total cost of ownership models comparing cloud-delivered security edge solutions against traditional hardware refreshes. The analysis of contract renewal lengths and software maintenance fees gave us clear visibility into enterprise replacement cycles over the next three to five years.
C

Cisco Systems

Technical Director

Scaling antibody-drug conjugate manufacturing hinges on contract manufacturing availability for high-potency active ingredients. The MetaStat Insight analysis looked closely at global cleanroom slot constraints, bioconjugation batch failure rates, and supply chain redundancies between the US, Europe, and India. The supplier capability matrix proved genuinely useful for our team when mapping secondary source options across our clinical pipeline.
A

AstraZeneca

Related Reports

Explore related market intelligence reports worth reading alongside this one.